References
- Cheson BD. Infectious and immunosuppressive complications of purine analog therapy. J Clin Oncol 1995; 13: 2431–48
- Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11: 954–63
- Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-y clinical study: new light on old controversies. Ophthalmologica 2003; 217: 239–59
- Proven A, Gabriel SE, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003; 49: 703–8
- Millar AB, Patou G, Miller RF, Grundy JE, Katz DR, Weller IV, et al. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?. Am Rev Respir Dis 1990; 141: 1474–7
- Bethel KJ, Sharpe RW. Pathology of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003; 16: 15–31
- Seymour JF, Kurzrock R, Freireich EJ, Estey EH. 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukaemia. Blood 1994; 83: 2906–11
- Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromized patients without HIV infection. Chest 2000; 118: 712–20
- Gluck T, Geerdes-Fenge HF, Straub RH, Raffenberg M, Lang B, Lode H, et al. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 2000; 28: 227–30